Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone
Purpose: To evaluate whether response assessment of newly diagnosed glioblastoma at 3 months using 11C-methionine-positron emission tomography (MET-PET) is better associated with patient outcome compared with baseline MET-PET or anatomic magnetic resonance imaging alone. Methods and Materials: Patie...
Main Authors: | Sean Miller, BS, Pin Li, MS, Matthew Schipper, PhD, Larry Junck, MD, Morand Piert, MD, Theodore S. Lawrence, MD, PhD, Christina Tsien, MD, Yue Cao, PhD, Michelle M. Kim, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109419301150 |
Similar Items
-
The Effect of Heterogenous Subregions in Glioblastomas on Survival Stratification: A Radiomics Analysis Using the Multimodality MRI
by: Lulu Yin MD, et al.
Published: (2021-07-01) -
Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
by: Gregory C. Stachelek, MD, PhD, et al.
Published: (2020-01-01) -
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
by: Daiki Ikarashi, MD, PhD, et al.
Published: (2021-10-01) -
Concomitant pancreatic neuroendocrine tumors in hereditary tumor syndromes: who, when and how to operate?
by: Xu Han, PhD, MD, et al.
Published: (2019-06-01) -
Tumor Suppressor Effect of RBMS3 in Breast Cancer
by: Chunyang Wang MD, PhD, et al.
Published: (2021-04-01)